Large Stem Cell-Derived Cardiomyocyte Grafts: Cellular Ventricular Assist Devices?

While the battle rages on about the endogenous repair capacity in the heart, solid work is progressing to take the promising exogenous pluripotent stem cells toward a clinical application.

Sian Harding is Professor of Cardiac Pharmacology at the National Heart and Lung Institute, Imperial College, as well as Institute Lead for Women for Athena Swan, and a co-investigator within the UKRMP Immunomodulation Hub.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Broken Heart Syndrome

Next Article

Gene therapy for heart failure: The end of the beginning?

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error: Faculti Content is protected. Please check our Privacy Policy and Terms and Conditions.

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×